相关实验视频

Updated: Sep 17, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

图CF:通过多特征融合与对比图神经网络进行药物向相互作用预测

Dianlei Gao¹, Fei Zhu¹

¹School of Computer Science and Technology, Soochow University, Suzhou, China.

Artificial intelligence in medicine

|July 2, 2025

概括

通过整合多模式数据,包括3D结构,以准确预测药物向相互作用 (DTI),GraphCF增强了药物发现. 这种新的方法提高了候选药物选和重新定位效率.

科学领域:

生物信息学是一种生物信息学.
计算化学计算化学
药物发现药物发现药物发现

背景情况:

药物向相互作用 (DTI) 的预测对于识别有效药物至关重要.
当前的DTI方法往往忽视3D结构信息,并与多模式功能集成作斗争.
需要采用全面的方法来捕捉各种药物和向特征.

研究的目的:

提出GraphCF,一种用于增强DTI预测的新型多模式交互融合方法.
有效地整合2D表示,序列特征和药物和目标的3D结构信息.
提高DTI预测模型的准确性和全面性.

主要方法:

GraphCF使用MixHop聚合器来获得更高阶的网络信息,以及用于歧视性2D表示的图形对比学习.
卷积神经网络 (CNN) 和图形神经网络 (GNN) 分别提取序列和3D结构特征.
交叉注意力机制融合了多模式特征,以改善交互表示.

主要成果:

在四个公共数据集上,GraphCF与先进方法相比,表现出了竞争力的表现.
该方法有效地整合了各种数据模式,包括关键的3D结构信息.
增强的特征融合导致了更准确的DTI预测.

结论:

GraphCF提供了一个强大的多模式DTI预测框架,优于现有的方法.
整合3D结构和先进的功能融合显著提高了DTI预测能力.
这种方法有望加速药物发现和重新定位努力.

关键词:

交叉注意力交叉注意力交叉注意力药物目标相互作用图表对比学习学习的图表.多模式融合多模式融合拓网络是一个拓网络.

更多相关视频

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

相关概念视频

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Predicting Reaction Outcomes

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...

Drug-Receptor Interaction: Antagonist

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...